By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration passed trade secrets …
pharmaceuticals
-
-
Nov 15 (Reuters) – Canadian wholesale trade increased by 0.1% in September from August on the higher sales in the personal and household goods subsector, and in particular pharmaceutical products, …
-
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix …
-
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnology™ (Luzsana)
Luzsana to co-develop medicines with parent company Hengrui Pharma and commercialize in North America, Europe and Japan Initial pipeline focuses on 11 high-potential programs in areas of high unmet need, …
-
NEW ORLEANS, April 22, 2022 — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces …
-
SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
Featured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide) Research BRIDGEWATER, N.J., April 7, 2022 — Salix Pharmaceuticals (“Salix”), the gastroenterology business of Bausch Health Companies Inc. (NYSE/TSX: BHC) …
-
Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion, USP to address current market shortage Tweet this About Propofol Propofol injectable emulsion is an intravenous general anesthetic and sedation …
-
VANCOUVER, BC, March 30, 2022 — The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the …
-
“We are pleased to collaborate with Seton Pharmaceuticals for the commercial launch of Butalbital, Acetaminophen and Caffeine Capsules in the U.S. market” stated Dhananjay Barot, Director, Senores Pharmaceuticals, Inc. “Our unfaltering …